Results 111 to 120 of about 4,142 (135)
Corneal pseudomicrocysts following claudin-6 antibody-drug conjugate infusion. [PDF]
Matuszewska L +5 more
europepmc +1 more source
Iris cerclage with goniosynechialysis and canalicular stent for neovascular angle closure glaucoma. [PDF]
Mahjabin F, Libre PE.
europepmc +1 more source
Topical medications for moderate-to-severe rosacea: protocol for a living systematic review and network meta-analysis. [PDF]
Amstutz AV +3 more
europepmc +1 more source
Inferior exten filtering bleb formation after laser goniopuncture in a patient with conjunctivochalasis. [PDF]
Alhazmi A, Alharthi F, Qedair J.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2023
Brimonidine is a highly selective 2-adrenoceptor agonist that lowers intraocular pressure (IOP) by decreasing aqueous humor production and increasing aqueous humor outflow via the uveoscleral route. Brimonidine is used to treat glaucoma and other eye conditions.
Ahmed H, Bakheit +3 more
openaire +2 more sources
Brimonidine is a highly selective 2-adrenoceptor agonist that lowers intraocular pressure (IOP) by decreasing aqueous humor production and increasing aqueous humor outflow via the uveoscleral route. Brimonidine is used to treat glaucoma and other eye conditions.
Ahmed H, Bakheit +3 more
openaire +2 more sources
Expert Opinion on Investigational Drugs, 1997
Brimonidine tartrate is a highly selective alpha2-adrenergic receptor agonist indicated for the chronic treatment of glaucoma and ocular hypertension. Glaucoma, a serious worldwide public health problem causing blindness in 5.2 million people, is treated by drugs that lower the intraocular pressure (IOP), a primary risk factor in glaucomatous optic ...
L B, Cantor, J, Burke
openaire +2 more sources
Brimonidine tartrate is a highly selective alpha2-adrenergic receptor agonist indicated for the chronic treatment of glaucoma and ocular hypertension. Glaucoma, a serious worldwide public health problem causing blindness in 5.2 million people, is treated by drugs that lower the intraocular pressure (IOP), a primary risk factor in glaucomatous optic ...
L B, Cantor, J, Burke
openaire +2 more sources
Journal of the Dermatology Nurses' Association, 2018
ABSTRACT A drug is a particular substance in physiology that exerts an effect when ingested or otherwise introduced into the body. Drugs may be administered in a variety of constitutions from capsules, injections, creams, and ointments to inhalants, liquids, and dermal patches; via different routes, namely, topical, parenteral, and inhalation;
Brittanya Limone, Janiene Luke
openaire +2 more sources
ABSTRACT A drug is a particular substance in physiology that exerts an effect when ingested or otherwise introduced into the body. Drugs may be administered in a variety of constitutions from capsules, injections, creams, and ointments to inhalants, liquids, and dermal patches; via different routes, namely, topical, parenteral, and inhalation;
Brittanya Limone, Janiene Luke
openaire +2 more sources

